Angene Chemical
Draw
|
Currency :
Home Products

AG003TIR

53716-50-0 | Oxfendazole

Chemical structure of Oxfendazole, CAS 53716-50-0
AG003TIR
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 53716-50-0
Catalog Number AG003TIR(AGN-PC-0OBY28)
Chemical Name Oxfendazole
EC Number 258-714-5
IUPAC Name methyl N-[6-(benzenesulfinyl)-1H-benzimidazol-2-yl]carbamate
InChI InChI=1S/C15H13N3O3S/c1-21-15(19)18-14-16-12-8-7-11(9-13(12)17-14)22(20)10-5-3-2-4-6-10/h2-9H,1H3,(H2,16,17,18,19)
InChI Key BEZZFPOZAYTVHN-UHFFFAOYSA-N
MDL Number MFCD00801063
Molecular Formula C15H13N3O3S
Molecular Weight 315.3470
NSC Number 758943
SMILES O=C(OC)NC1=NC2=CC=C(S(C3=CC=CC=C3)=O)C=C2N1
UNII OMP2H17F9E
Synonyms
FBZ-SO, fenbendazole sulfoxide, methyl 5(6)-phenylsulfinyl-2-benzimidazolecarbamate, oxfendazole, oxfendazole monohydrochloride, RS 8858, Synanthic, Oxfendazole, 53716-50-0, Fenbendazole sulfoxide, Synanthic, Systamex, OFDZ, Repidose, Systemax, Oxfendazolum, Oxfendazol, Synanthic (Veterinary), RS-8858, fenbendazole S-oxide, RS 8858, 5-Phenylsulfinyl-2-carbomethoxyaminobenzimidazole, Oxfendazol [INN-Spanish], Oxfendazolum [INN-Latin], UNII-OMP2H17F9E, HOE 8105, methyl [5-(phenylsulfinyl)-1H-benzimidazol-2-yl]carbamate, Oxfendazole [USAN:BAN:INN], Methyl 5-(phenylsulfinyl)-2-benzimidazolecarbamate, Oxfendazole (USP/INN), EINECS 258-714-5, 5-(Phenylsulfinyl)-2-benzimidazolecarbamic acid methyl ester, Methyl 5-(phenylsulfinyl)-benzimidazol-2-carbamate, (5-(Phenylsulfinyl)-1H-benzimidazol-2-yl)carbamic acid methyl ester, BRN 0761290, OMP2H17F9E, CHEMBL42442, Methyl (5-phenylsulfinyl)-1H-benzimidazol-2-yl carbamate, C15H13N3O3S, CHEBI:35812, methyl 5(6)-phenylsulfinyl-2-benzimidazolecarbamate, NCGC00095157-04, 2-Benzimidazolecarbamic acid, 5-(phenylsulfinyl)-, methyl ester, [5-(Phenylsulfinyl)-1H-benzimidazol-2-yl]carbamic acid methyl ester, CARBAMIC ACID, (5-(PHENYLSULFINYL)-1H-BENZIMIDAZOL-2-YL)-, METHYL ESTER, Carbamic acid, [5-(phenylsulfinyl)-1H-benzimidazol-2-yl]-, methyl ester, DSSTox_CID_24112, DSSTox_RID_80103, DSSTox_GSID_44112, Q-201525, methyl N-[5-(benzenesulfinyl)-1H-benzimidazol-2-yl]carbamate, methyl N-[6-(benzenesulfinyl)-1H-benzimidazol-2-yl]carbamate, Carbamic acid, 5-(phenylsulfinyl)-1H-benzimidazol-2-yl-, methyl ester, CAS-53716-50-0, Oxfenbendazole, Oxphendazole, Benzelmin, Nanthic, CCRIS 9430, Synanthic (TN), Oxfendazole [USAN:USP:INN:BAN], Spectrum2_001704, Spectrum3_001972, Oprea1_563224, SCHEMBL44121, BSPBio_003572, MLS004712073, Synanthic [veterinary] (TN), SPECTRUM1505296, SPBio_001688, (+/-)-Fenbendazole Sulfoxide, AC1L24M4, SCHEMBL9818561, DTXSID9044112, CTK8E8695, KBio3_002947, BEZZFPOZAYTVHN-UHFFFAOYSA-N, HMS1922B08, HMS2090F19, HMS2093O16, HMS3655M14, HMS3715E09, Pharmakon1600-01505296, BCP09602, HY-B0291, Oxfendazole (Fenbendazole Sulfoxide), Tox21_113444, Tox21_302383, BDBM50300124, CCG-39503, MFCD00801063, NSC758943, s1830, STK378905, Fenbendazole Sulphoxide (Oxfendazole), AKOS005448898, AKOS015918230, Tox21_113444_1, AC-8715, AN-7766, CCG-220984, CS-2305, KS-5036, MCULE-2247044354, NSC-758943, NCGC00095157-01, NCGC00095157-02, NCGC00095157-03, NCGC00095157-05, NCGC00095157-06, NCGC00255714-01, AK546755, BC203983, CC-33414, H844, LS-50557, SC-18524, SMR001550468, SBI-0206760.P001, AB0013301, AB2000317, TL8003524, TR-037021, FT-0630662, O0391, ST50865840, SW199450-2, C21882, D05291, AB01275512-01, AB01275512_02, AB01275512_03, Oxfendazole, VETRANAL(TM), analytical standard, 716O500, A829749, C-19436, SR-01000872713, I14-7817, SR-01000872713-1, BRD-A33447119-001-02-5, BRD-A33447119-001-03-3, BRD-A33447119-001-05-8, Methyl (5-Benzenesulfinyl-2-benzimidazol-yl)carbamate, Methyl [5-(Phenylsulfinyl)benzimidazol-2-yl]carbamate, methoxy-N-[5-(phenylsulfinyl)benzimidazol-2-yl]carboxamide, Oxfendazole, European Pharmacopoeia (EP) Reference Standard, methyl (6-(phenylsulfinyl)-1H-benzo[d]imidazol-2-yl)carbamate, methyl 5-(phenylsulfinyl)-1H-benzo[d]imidazol-2-ylcarbamate, METHYL 6-(PHENYLSULFINYL)-1H-BENZIMIDAZOL-2-YLCARBAMATE, methyl 6-(phenylsulfinyl)-1H-benzo[d]imidazol-2-ylcarbamate, methyl N-[6-(phenylsulfinyl)-1H-benzimidazol-2-yl]carbamate, [5-(Phenylsulfinyl)benzimidazol-2-yl]carbamic Acid Methyl Ester, Methyl [5-(phenylsulfinyl)-1H-benzimidazol-2-yl]carbamate, 9CI, methyl N-[5-(benzenesulfinyl)-1H-1,3-benzodiazol-2-yl]carbamate, Oxfendazole, United States Pharmacopeia (USP) Reference Standard, Carbamic acid, N-[6-(phenylsulfinyl)-1H-benzimidazol-2-yl]-, methyl ester, N-[6-(benzenesulfinyl)-1H-benzimidazol-2-yl]carbamic acid methyl ester, Methyl [5-(Phenylsulfinyl)benzimidazol-2-yl]carbamate / [5-(Phenylsulfinyl)benzimidazol-2-yl]carbamic Acid Methyl Ester, null, Oxibendazole, FBZ-SO, oxfendazole monohydrochloride, Oxfendazole [USAN:INN:BAN], Oxfendazole, 99% - 1G 1g, CID40854, C15-H13-N3-O3-S, B1998, C011030, methyl-5-(phenylsulfinyl)-2-benzimidazolecarbamate, methyl N-(6-phenylsulfinyl-1H-benzimidazol-2-yl)carbamate, 20559-55-1,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited